Newron Pharmaceuticals SpA Net Asset Quality Index
Newron Pharmaceuticals SpA net asset quality index. Newron Pharmaceuticals SpA (NWRN) has a Net Asset Quality Index of -27.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF40.02 Million minus total liabilities of CHF51.15 Million yields net assets of CHF-11.13 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Newron Pharmaceuticals SpA shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Newron Pharmaceuticals SpA (2005–2025)
Net asset quality index of Newron Pharmaceuticals SpA from 2005 to 2025. This chart shows how Newron Pharmaceuticals SpA's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the index stands at -27.8%, representing net assets of CHF-11.13 Million against total assets of CHF40.02 Million CHF. Check asset allocation strategy of Newron Pharmaceuticals SpA to assess the company's strategic physical and investment asset allocation.
Newron Pharmaceuticals SpA Net Asset Quality Index by Year (2005–2025)
Newron Pharmaceuticals SpA net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for Newron Pharmaceuticals SpA from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Newron Pharmaceuticals SpA.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -27.8% | CHF-11.13 Million | CHF40.02 Million | CHF51.15 Million | ▼ -30.1 pp |
| 2024 | 2.3% | CHF1.46 Million | CHF63.91 Million | CHF62.45 Million | ▲ +117.9 pp |
| 2023 | -115.6% | CHF-29.91 Million | CHF25.87 Million | CHF55.77 Million | ▼ -77.9 pp |
| 2022 | -37.7% | CHF-14.03 Million | CHF37.20 Million | CHF51.23 Million | ▼ -43.9 pp |
| 2021 | 6.2% | CHF3.11 Million | CHF50.49 Million | CHF47.38 Million | ▼ -27.5 pp |
| 2020 | 33.7% | CHF17.25 Million | CHF51.20 Million | CHF33.95 Million | ▼ -27.4 pp |
| 2019 | 61.0% | CHF36.80 Million | CHF60.29 Million | CHF23.49 Million | ▼ -30.4 pp |
| 2018 | 91.4% | CHF54.84 Million | CHF60.00 Million | CHF5.16 Million | ▼ -1.3 pp |
| 2017 | 92.7% | CHF67.72 Million | CHF73.02 Million | CHF5.30 Million | ▲ +4.8 pp |
| 2016 | 87.9% | CHF49.75 Million | CHF56.59 Million | CHF6.84 Million | ▲ +4.3 pp |
| 2015 | 83.6% | CHF37.11 Million | CHF44.38 Million | CHF7.27 Million | ▲ +4.7 pp |
| 2014 | 78.9% | CHF29.26 Million | CHF37.07 Million | CHF7.81 Million | ▲ +12.2 pp |
| 2013 | 66.7% | CHF21.09 Million | CHF31.62 Million | CHF10.53 Million | ▲ +4.9 pp |
| 2012 | 61.8% | CHF27.61 Million | CHF44.65 Million | CHF17.04 Million | ▲ +13.3 pp |
| 2011 | 48.5% | CHF6.58 Million | CHF13.57 Million | CHF6.98 Million | ▼ -15.2 pp |
| 2010 | 63.7% | CHF12.19 Million | CHF19.13 Million | CHF6.94 Million | ▼ -6.5 pp |
| 2009 | 70.3% | CHF29.28 Million | CHF41.68 Million | CHF12.39 Million | ▼ -5.4 pp |
| 2008 | 75.7% | CHF45.81 Million | CHF60.54 Million | CHF14.73 Million | ▼ -5.9 pp |
| 2007 | 81.6% | CHF57.40 Million | CHF70.37 Million | CHF12.97 Million | ▲ +2.8 pp |
| 2006 | 78.8% | CHF67.86 Million | CHF86.16 Million | CHF18.30 Million | ▲ +6.3 pp |
| 2005 | 72.4% | CHF17.02 Million | CHF23.50 Million | CHF6.48 Million | — |